Sanofi Jobs

A new perspective. A new challenge. A new opportunity.

Job Information

Sanofi Group Head of Genomic Medicine Bioanalytics in Framingham, Massachusetts

Job Title: Head of Genomic Medicine Bioanalytics

Reporting to the Head of Bioanalytics, the Head of Genomic Medicine (GM) Bioanalytics will lead a group of approximately 45 scientists, involved in 1) the development, qualification and transfer of methods to internal and external commercial QC units, 2) characterization and comparability of gene and cell therapy molecules 3) analytical support for formulation, upstream and downstream development and 4) the generation and maintenance of an NGS core facility to support gene and cell therapies and protein biologics development. The GM Bioanalytics group will also be responsible for QC testing support for Preclinical, Phase 1, and Phase 2 cell and gene therapy molecules. The Head of GM will represent Bioanalytics on the GMU CMC leadership team and report through a dotted line to the Head of Genomic Medicine CMC.

Key Responsibilities:

  • Oversee the department’s GMP sample support, including IPC, release and stability testing, performed in house as well as at CROs. Provide oversight and guidance for GMP investigations including deviations root cause analyses, CAPA, and out-of-specifications.

  • Oversee the Bioprocess analytics group to ensure timely turnaround to support vector and cell line, process and formulation development.

  • Oversees the Characterization group to characterization and further understand structure functional relationships of lentivirus, AAV and cell therapies.

  • Oversees the development and maintenance of the NGS core team, who will be responsible for providing NGS support to vectorology, cell line selection, manufacturing support and product release and characterization (GMP and non GMP) for both Genomic Medicine and Biologics development.

  • Oversee the method development, qualification/validation and transfer of analytical methods to and from the GM analytics teams by collaborating internally with research and MSAT teams and externally with CROs/CMOs.

  • Set the strategy for evaluating and implementing new technologies within the GM Bioanalytics group, with an emphasis on state-of-the-art separation sciences, cell based and molecular technologies and automation. Collaborate with Bioanalytics assay cell line selection and automation skill centers to achieve this goal.

  • Provide strong scientific mentorship to direct reports who have both managerial and CMC analytical project leadership roles that support process development, specification setting, and CMC regulatory filings and responses.

  • Collaborates within the Genomic Medicine Unit and Bioanalytics teams to streamline our WOW to ensure quality but improve efficiency and cost of goods.

  • Design and adapt analytical paradigms based on the CQAs, process control strategies and emerging industry trends.

  • Take a leading role in setting Sanofi company-wide strategic analytical initiatives for ATMPs, including authoring guidance documents.

  • Manages and oversee the long- and short-term planning and supervision of projects, by prioritizing and determining group goals to achieve company objectives.

  • Develops, hires and maintains key personnel in the group.

  • Provides technical and regulatory guidance to ensure that the methods and products are developed in accordance with company and industry standards.

  • Collaborates on patent applications and manuscripts for publication.

  • Represents the company as a contact person for external contracts and collaborations.

Basic Qualifications:

  • PhD Degree in a cell or molecular biology or related discipline with a minimum of 12 years of relevant industry experience, or Master’s or Bachelor’s degree with a minimum of 16 years of relevant industry experience

  • Minimum of 7 years of managerial experience.

  • Expertise in cell and gene therapy analytics e.g. for AAV, Lentivirus and/or cell therapies, as well as a strong understanding of cell and molecular biology.

  • An understanding of regulatory requirements and trends related to analytics and product development for gene and cell therapies.

  • Experience leading teams in the development, qualification/validation and transfer of analytical methods and working in a GMP environment.

  • Experience in planning and implementing analytical and CMC strategy for the development of AAV, Lentivirus and/or cell therapies.

  • Experience acting as an analytical team leader

  • Experience writing regulatory submissions, audits and meetings.

  • Understanding of how QbD, CQAs and process control strategies are related.

  • Excellent communication skills.

Preferred Qualifications:

  • Experience developing and implementing analytical platforms using QbD.

  • Proven experience streamlining WOW to ensure quality but improve efficiency and reduce costs.

  • Experience acting as a CMC project leader.

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.



At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.